Reaction #4065723
Related Literature (1)
openreactiondata ↗doi:10.1039/C8SC04228D
Conditions: temp:0.00; pressure:0.00; stir:
Source ID: ord-03328c8fc39f47039c85daa75b925395No renderable structure data available
BrC1=CC2=CC=CC=C2O1Chemical Intermediate
Structures, identifiers and computed properties have been matched to the database record by CAS.
| Intermediates | 2-BROMO-1-BENZOFURAN |
|---|---|
| IUPAC Name | — |
| CAS Number | 54008-77-4 |
| Database ID | 2776264 |
| Molecular Formula | — |
| Molecular Weight | — |
Product Information
2-BROMO-1-BENZOFURAN (CAS 54008-77-4) product identity, structure identifiers and related reaction data for chemical intermediate research and sourcing review.
Potential Applications
For professional research and industrial use only
Database ID 2776264
Safety Notice
For professional research and industrial use only. Review the supplier safety data sheet before handling.
Synthesis data
12 reactions · 12 references
Conditions: temp:0.00; pressure:0.00; stir:
Source ID: ord-03328c8fc39f47039c85daa75b925395Conditions: temp:0.00; pressure:0.00; stir:
Source ID: ord-be97a1b20fca411d8e2bea0bf4657e86Conditions: temp:0.00; pressure:0.00; stir:
Source ID: ord-d267de8270e241daac1fe4f77b2fbf9cConditions: temp:0.00; pressure:0.00; stir:; See reaction.notes.procedure_details.
Procedure: The title compound was synthesized in a manner analogous to that described Example 408, using (R)-methyl 2-(tert-butoxycarbonyl)-3-iodopropanoate and 2-bromobenzofuran. (MS m/z: 220.1 (100%, M-99).
Source ID: ord-efbe49208cfd42beb8487e96591ecd20Conditions: temp:0.00; pressure:0.00; stir:; See reaction.notes.procedure_details.
Procedure: The title compound was synthesized in a manner analogous to that described Example 408, using (R)-methyl 2-(tert-butoxycarbonyl)-3-iodopropanoate and 2-bromobenzofuran. (MS m/z: 220.1 (100%, M-99).
Source ID: ord-efbe49208cfd42beb8487e96591ecd20Conditions: temp:0.00; pressure:0.00; stir:; See reaction.notes.procedure_details.
Procedure: The title compound was synthesized in a manner analogous to that described Example 475, using (R)-methyl 2-(tert-butoxycarbonyl)-3-iodopropanoate and 2-bromobenzofuran. (MS m/z: 220.1 (100%, M−99).
Source ID: ord-fb370dd91b654782ae878d757c41d2bdConditions: temp:0.00; pressure:0.00; stir:; See reaction.notes.procedure_details.
Procedure: The title compound was synthesized in a manner analogous to that described Example 475, using (R)-methyl 2-(tert-butoxycarbonyl)-3-iodopropanoate and 2-bromobenzofuran. (MS m/z: 220.1 (100%, M−99).
Source ID: ord-fb370dd91b654782ae878d757c41d2bdConditions: temp:0.00; pressure:0.00; stir:
Source ID: ord-03328c8fc39f47039c85daa75b925395Conditions: temp:0.00; pressure:0.00; stir:
Source ID: ord-be97a1b20fca411d8e2bea0bf4657e86Conditions: temp:0.00; pressure:0.00; stir:
Source ID: ord-d267de8270e241daac1fe4f77b2fbf9cConditions: temp:0.00; pressure:0.00; stir:; See reaction.notes.procedure_details.
Procedure: A 10 mL flame-dried RBF was loaded with a stir-bar, 2-bromo-1-benzofuran (160.3 mg, 0.81 mmol), and ether (3 mL). An addition 10 mL flame-dried RBF was loaded with a stir bar, artemisinin (67.4 mg, 0.24 mmol) and THF (3 mL). Both flasks were immersed into dry ice/acetone baths and n-BuLi (0.33 mL, 1.6 M sol, 0.53 mmol) was added over 14 minutes to the flask containing the 2-bromo-1-benzofuran which was then stirred at RT for nine minutes. The flask was then re-immersed in the dry ice/acetone bath. The resulting solution became pale yellow. After 41 additional minutes, the artemisinin solution was added via cannula and the resulting solution became deeper orange in color. After 30 minutes of stirring at −78° C., the TLC showed consumption of artemisinin and the formation of 2 new spots, with a lower Rf. Acetic anhydride (0.14 mL, 1.51 mmol) was added 25 minutes later. After for 2 hours, the new spot was observed to have disappeared, triethylsilane (0.68 mL, 4.21 mmol), and trimethylsilyl trifluorosulfonate (0.58 mL, 3.2 mmol) were added and the reaction became fuchsia in color. Then, TEA (2 mL) was added 2.5 hours later. The reaction was then poured into a reparatory funnel containing dichloromethane and saturated aqueous sodium bicarbonate. The organic layer was washed with saturated aqueous sodium bicarbonate (3×30 mL). The organic layer was then washed with saturated aqueous sodium chloride, dried over magnesium sulfate, filtered, and evaporated. The residue was purified using two flash chromatography columns (first column: silica gel, packed with 100% hexanes, eluted with 5% ethyl acetate in hexanes; second column: silica gel, packed with 100% hexanes, eluted with 50% dichloromethane in hexanes) to give the product as a yellow film that turned into a foamy solid on prolonged high-vacuum drying (17.3 mg, 0.05 mmol, 19%). 1H NMR (CDCl3, 400 MHz): δ 7.59-7.57 (m, 1H), 7.53-7.48 (m, 2H), 7.39-7.18 (m, 2H), 6.91 (s, 1H), 5.79 (s, 1H), 2.49-2.41 (m, 1H), 2.15-2.00 (m, 5H), 2-1.92 (m, 2H), 1.79-1.73 (m 1H), 1.65-1.30 (m, 8H), 1.22-1.15 (m, 1H), 1.04-1.03 (d, J=4 Hz, 3H). 13C NMR (CDCl3, 100 MHz): δ 154.5, 152.1, 136.1, 128.3, 124.0, 122.7, 120.9, 111.2, 109.4, 105.1, 104.6, 90.1, 78.6, 50.9, 47.6, 37.7, 36.3, 34.2, 29.2, 25.8, 24.5, 20.2, 17. IR (thin film): 2927, 2365, 2331, 1459, 1134, 1027. HRMS (FAB+): calculated for C23H26O5: 382.1780, found 382.1785. [α]D26=+41.0 (c 1.25, CHCl3) A 10 mL flame-dried RBF was loaded with a stir-bar An addition 10 mL flame-dried RBF was loaded with a stir bar was added over 14 minutes to the flask After 30 minutes of stirring at −78° C. consumption of artemisinin After for 2 hours The reaction was then poured into a reparatory funnel The organic layer was washed with saturated aqueous sodium bicarbonate (3×30 mL) The organic layer was then washed with saturated aqueous sodium chloride dried over magnesium sulfate filtered evaporated The residue was purified two flash chromatography columns (first column: silica gel, packed with 100% hexanes, eluted with 5% ethyl acetate in hexanes; second column: silica gel, packed with 100% hexanes, eluted with 50% dichloromethane in hexanes) to give the product as a yellow film that drying (17.3 mg, 0.05 mmol, 19%)
Source ID: ord-f35b9b211d7a4844b4005070548867a1Conditions: temp:0.00; pressure:0.00; stir:; See reaction.notes.procedure_details.
Procedure: Alternatively, the starting bromobenzofuran may be reacted with magnesium metal under standard conditions to prepare the corresponding Grignard reagent, benzofurylmagnesium bromide. This Grignard reagent is then reacted with the Weinreb amide, N-methyl N-methoxy 1-(tert-butoxycarbonylamino)cyclopropane-1-carboxamide, to provide 1-(tert-butoxycarbonylamino)-1-(benzofurylcarbonyl)cyclopropane. This ketone is then reduced under standard conditions, typically with sodium borohydride in methanol or ethanol, to provide 1-(tert-butoxycarbonylamino)-1-(benzofuryl(hydroxymethyl))cyclopropane. This alcohol is then converted to the corresponding acetate and reduced to the corresponding methylene by treatment with samarium iodide as previously described. The resulting 1-(tert-butoxycarbon-yl)-1-(benzofurylmethyl)cyclopropane is treated with acid under standard conditions to provide the compounds of the present invention. If necessary or desired, the Weinreb amide may be reduced by reaction with lithium aluminum hydride to provide the corresponding aldehyde essentially as described by Fehrentz and Castro (Synthesis, 676 (1983)). This aldehyde is then reacted with the Grignard reagent previously described to prepare 1-(tert-butoxycarbonylamino)-1-(benzofuryl(hydroxymethyl))cyclopropane, which is then subjected to the reaction conditions previously described to prepare the compounds of the present invention. The requisite Weinreb amide, N-methyl N-methoxy 1-(tert-butoxycarbonylamino)cyclopropane-1-carboxamide, may be prepared from the commercially available 1-amino-1-carboxycyclopropane by standard methods well known in the art.
Source ID: ord-f06142904c7a4356838633795e734905PubChem References
These sources are listed in the compound's public database record.
Request a Quote
Send the required specification, quantity, destination and intended use. The CATO team will review availability and respond.
